Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models
Giuliana Cassinelli(Fondazione IRCCS Istituto Nazionale dei Tumori), Franco Zunino(University of California, Berkeley), Denis Cominetti(Fondazione IRCCS Istituto Nazionale dei Tumori), Cinzia Lanzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Israël Vlodavsky(Technion – Israel Institute of Technology), Claudio Pisano(Sigma Tau (Italy)), Giovanna Petrangolini, Monica Tortoreto(Fondazione IRCCS Istituto Nazionale dei Tumori), Sergio Penco(Sigma Tau (Italy)), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Enrica Favini(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 81
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.
|PubMed|1988|877
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348